A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PROOF OF CONCEPT STUDY TO ASSESS THE SAFETY AND EFFICACY OF ELEZANUMAB IN ACUTE TRAUMATIC CERVICAL SPINAL CORD INJURY

Registry ID

M16-077

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

ABBVIE CORPORATION

Start date

2022-03-28

Completion date

2025-03-04

Last update

2019-12-17

Conditions

• SPINAL CORD INJURY
• CERVICAL SPINAL CORD INJURY

Related clinical trials

• EFFECTS OF THE SEROTONIN PRECURSOR, 5-HYDROXYTRYPTOPHAN (5-HTP), ON THE INJURED HUMAN SPINAL CORD
• CAN BRIEF EXPOSURE TO HYPEROXIA IMPROVE FUNCTION AFTER CHRONIC SPINAL CORD INJURY?
• EFFECTS OF BACLOFEN ON PRESYNAPTIC INHIBITION IN HUMANS
• A PHASE 2B/3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF VX-210 IN SUBJECTS WITH ACUTE TRAUMATIC CERVICAL SPINAL CORD INJURY

View on source registry